dr. mark scholz on using abiraterone in mcrpc
Published 9 years ago • 915 plays • Length 1:27
Download video MP4
Download video MP3
Similar videos
-
0:54
convincing long-term survival with abiraterone in mcrpc
-
0:56
dr. mark scholz on advances in prostate cancer imaging
-
5:08
is seminal vesicle invasion considered metastatic disease? | mark scholz, md | pcri
-
19:52
a medical oncologist compares surgery and radiation for prostate cancer | mark scholz, md | pcri
-
1:27
dr. scholz on significance of aramis trial in crpc
-
15:58
understanding intermittent hormone therapy for #prostatecancer | #markscholzmd #alexscholz #pcri
-
14:06
intermediate-risk: do you need hormone therapy with radiation? | #markscholzmd #alexscholz #pcri
-
8:06
psa less than 0.01 - next steps, testosterone after hormone therapy | answering youtube comments #58
-
2:05
abiraterone in metastatic castration-sensitive prostate cancer
-
8:44
finding an oncologist for advanced disease | scanning for metastases early | mark scholz, md | pcri
-
12:56
radiation and hormone therapy | prostate cancer | mark scholz, md | pcri
-
3:11
what to know before making a treatment decision | ask a prostate expert, mark scholz, md
-
1:20
dr. hwang on the addition of radium-223 to abiraterone acetate and prednisone in mcrpc
-
3:31
side effects: sbrt, imrt, & brachytherapy | answering youtube comments, mark scholz, md | pcri #19
-
16:41
developments in prostate cancer treatment with dr. mark scholz medical oncologist
-
2:16
cou-aa-302: abiraterone in pre-chemo crpc
-
26:00
treating side effects of hormone therapy | #markscholzmd #alexscholz #pcri
-
2:30
is abiraterone acetate useful for prostate cancer?
-
8:56
abiraterone in metastatic prostate cancer
-
5:17
abiraterone alone likely suppresses testosterone sufficiently in mcrpc patients | carsten ohlmann
-
9:40
proton therapy, imrt, and sbrt | mark scholz, md | pcri
-
2:41
quality of life and survival with abiraterone in advanced prostate cancer
Clip.africa.com - Privacy-policy